Traditional Chinese medicinal composition for treating fatty liver and preparation method of traditional Chinese medicinal composition

Abstract

The invention relates to a traditional Chinese medicinal composition for treating fatty liver. The traditional Chinese medicinal composition is characterized by being prepared from the following raw material components in parts by weight: 10 to 15 parts by weight of radix rehmanniae, 15 to 20 parts by weight of radix astragali seu hedysari, 15 to 20 parts by weight of radix scutellariae, 15 to 20 parts by weight of fructus gardenia, 15 to 20 parts by weight of herba artemisiae scopariae, 15 to 20 parts by weight of radix curcumae, 15 to 20 parts by weight of radix salviae miltiorrhizae, 15 to 20 parts of rhizoma polygoni cuspidate, 15 to 20 parts by weight of elephantopus herb, 15 to 20 parts by weight of radix aucklandiae, 15 to 20 parts by weight of fructus crataegi, 15 to 20 parts by weight of radix puerariae, 15 to 20 parts by weight of fructus jujubae, 10 to 15 parts by weight of fructus mume, 15 to 20 parts by weight of semen cassia, 15 to 20 parts by weight of obscured homalomena rhizome and 15 to 20 parts by weight of creeping dichondra herb. The traditional Chinese medicinal composition provided by the invention has the functions of removing dampness and resolving stasis, tonifying Qi and smoothing liver, and nourishing Yin and liver, and has an excellent prevention and treatment effect on the fatty liver; in addition, the traditional Chinese medicinal composition has the advantages of convenience in use, lower cost and good business prospect.

Description

technical field [0001] The invention relates to the technical field of Chinese herbal medicines, in particular to a Chinese medicine composition for treating fatty liver and a preparation method thereof. Background technique [0002] In recent years, with the continuous improvement of people's material life in our country, the incidence of fatty liver in my country has increased year by year, accounting for 10% of the average population, becoming the second largest liver disease after viral hepatitis, and has been recognized as a hidden disease. common cause of liver cirrhosis. Fatty liver refers to when the lipid accumulation in the liver cells exceeds 5%, or when more than one-third of the liver cells per unit area are histologically fatty. The pathogenesis of fatty liver has not yet been clarified. Modern medicine believes that it may be related to various factors, such as abnormal lipid metabolism, changes in hormone levels, environmental and genetic factors, lipid perox...

AI Technical Summary

Problems solved by technology

Most of these drugs are aimed at a certain link or part of the pathogenesis of fatty liver. The effect is relatively single, and the effect is not ideal.

In addition, lipid-lowering drugs may tend to concentrate blood lipids in the liver for metabolism, increase the burden on the liver, and instead promote the accumulation of lipids in the liver and damage liver function. Therefore, patients with fatty liver should not blindly take lipid-lowering drugs for a long time

Images